Phytomenadione

维生素K1

Report date: 2023/12/06 14:02:51
NME

Base Information

Drug NamePhytomenadione
Drug Alias Namephytomenadionum植物甲萘醌Vitamin K1PhytonadionePhylloquinone +[10] 
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHemorrhageVitamin K Deficiency BleedingVitamin K Deficiency +[9] 
Global Approved IndicationsVitamin K DeficiencyHypoprothrombinemias
Approved Indications in ChinaVitamin K Deficiency
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesEisai LtdWuxi No 7 Pharmaceutical Co Ltd
Inactive CompaniesPharmaceutical Associates IncUniversity Of Western OntarioMcmaster University +[6] 
Active IndicationsVitamin K Deficiency
Inactive IndicationsHemorrhageVitamin K Deficiency BleedingHypoprothrombinemias +[8] 

Other Information

ATC CodeB02BA01
Related LinksWikipediaDrugBankKEGG